Compound trans - 4 - {2 - [4 - (2,3-dichlorophenyl) piperazin-1-yl] ethyl} - n, N - DIMETHYLCARBAMOYL - cyclohexylamine, their salts, hydrates and polymorphs, solvates, use in the primary Treatment of negative symptoms of schizophrenia.
PITTER, JÁNOS GYÖRGY,SZATMÁRI, BALÁZS,DEBELLE, MARC,NÉMETH, GYÖRGY JÓZSEF,LASZLOVSZKY, ISTVÁN
申请号：
CL2015001468
公开号：
CL2015001468A1
申请日:
2015.05.29
申请国别(地区):
CL
年份:
2015
代理人:
摘要：
The present invention relates to trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine (cariprazine) and pharmaceutically acceptable salts and hydrates and solvates and polymorphs thereof for use in the treatment of primary negative symptoms of schizophrenia and/or predominantly negative symptoms of schizophrenia.USO DEL COMPUESTO TRANS-4-{2-[4-(2,3-DICLOROFENIL)-PIPERAZIN-1-IL]-ETIL}-N,N-DIMETILCARBAMOIL-CICLOHEXILAMINA； PARA EL TRATAMIENTO DE SÍNTOMAS NEGATIVOS PRIMARIOS DE LA ESQUIZOFRENIA Y/O SÍNTOMAS PREDOMINANTEMENTE NEGATIVOS DE LA ESQUIZOFRENIA
